Energizing Iron

Ferrous bisglycinate is paired with vitamin C, folate, and vitamin B12, creating a more complete and transparent iron formula. The 28 mg dose is substantially higher than the original and should match a confirmed need.

A 27 mg Ferrochel dose with vitamin C, folate, and vitamin B12 offers clearer iron-focused support than liver fractions of uncertain composition. Dong quai adds little to the core purpose and may increase bleeding tendency with anticoagulant or antiplatelet medicines.

A single 36 mg ferrous bisglycinate ingredient is straightforward to assess and uses a well-absorbed form. The dose is much higher and lacks vitamin B12, so it is better only for a confirmed higher iron requirement.

A clearly stated 18 mg Ferrochel iron dose provides a focused, lower-cost alternative without undisclosed liver fractions. It omits vitamin B12, so it fits only when iron rather than combined iron and B12 support is needed.

A defined 18 mg TRAACS Ferrochel dose offers a simple, economical alternative to the original's duplicate iron entries. No vitamin B12 or other cofactors are included, so the formula is intentionally narrower.

Iron bisglycinate supplies a clear 27 mg amount at a lower recurring cost than the original. The higher dose and absence of vitamin B12 mean use should be tied to a demonstrated iron need.

Methylcobalamin, methylfolate, and active vitamin B6 offer strong value for a B-vitamin-centered goal. No iron is supplied, so it cannot replace the original when iron support is required.

A focused 18 mg ferrous bisglycinate dose provides a clear, economical iron option without liver-derived ingredients. Vitamin B12 and other cofactors are absent, but the label is simpler than the original.

A 27 mg Ferrochel dose combines clear disclosure with low recurring cost. The higher amount and lack of vitamin B12 make it a value option only for a documented iron need.